Tuesday, November 10, 2015 I 9:45am – 10:45am
Up-and-coming applications of precision medicine include rare diseases, cardiac care, autoimmune disorders and neurology. Researchers and clinicians are tapping into tools like stem cells, gene markers, and 3D imaging. This panel will peer into the future of precision medicine.
- Kenneth Mandl, MD, MPH, Professor at Harvard Medical School and Director of the Boston Children’s Computational Health Informatics Program
- George Church, PhD, Professor of Genetics at Harvard Medical School; Professor of Health Sciences and Technology at Harvard & MIT
- Matthew Might, PhD, Associate Professor in the School of Computing at the University of Utah
- Dominique Verhelle, PhD, MBA, Strategic Advisor at Third Rock Ventures
- Wendy Chung, MD, PhD, Herbert Irving Associate Professor of Pediatrics at Columbia University Medical Center
- Gregory Steinberg, MD, Head of Clinical Innovation at Aetna, Inc.
Moderated by Nicole Fisher, Founder + CEO of HHR Strategies and Health Innovation + Policy contributor at Forbes Magazine
See all of this year’s program participants >>